Investor Relations

News and Events

For additional information, please contact info@trovagene.com. or call 1-858-952-7593

Trovagene (TROV) Stock: Providing New Cancer Treatment Options With Onvansertib CNA Article

Please see write-up on Trovagene by CNA. Click Here to Read Article

H.C. Wainwright 23rd Annual Global Investment Conference

Cardiff Oncology Chief Executive Officer, Dr. Mark Erlander, and Chief Financial Officer, James Levine will participate in the H.C. Wainwright Investment Conference September 13th - 15th, 2021....

H.C. Wainwright 23rd Annual Global Investment Conference

Cardiff Oncology Chief Executive Officer, Dr. Mark Erlander, and Chief Financial Officer, James Levine will participate in the H.C. Wainwright Investment Conference September 13th - 15th, 2021....

H.C. Wainwright 23rd Annual Global Investment Conference

Cardiff Oncology Chief Executive Officer, Mark Erlander, and Chief Financial Officer, James Levine, will participate in the H.C. Wainwright Global Investment Conference Monday, September 13th...